Prevention of repeat unwanted pregnancy, choice of a contraceptive method


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review provides the results of investigations dealing with the most preferred birth control methods for women after termination of unwanted pregnancy, as well as a rationale for recommendations in terms of their evidence basis. Analysis of publications has shown that long-acting reversible contraception (intrauterine devices (IUD), implants, injections, and vaginal rings) is the method of first choice after abortion. Having regard to the clinical and economic effectiveness and acceptability of the methods, the IUD T- Cu 380А or implant are is most preferred. IUD insertion is recommended immediately (as compared with delayed insertion) after pregnancy termination, including that with the use of medications, which promotes an increase in the number of users and a decrease in the number of further unwanted pregnancies in the absence of increased risk for complications.

Full Text

Restricted Access

About the authors

Galina B. Dikke

Peoples' Friendship University of Russia

Email: galadikke@yandex.ru
Honoured Science and Education, MD, professor of obstetrics, gynecology and reproductive medicine faculty of continuing medical education

References

  1. Основные показатели здоровья матери и ребенка, деятельность службы охраны детства и родовспоможения в Российской Федерации. М.: МЗРФ; 2012
  2. Тихомиров А.Л., Батаева А.Е. Лучше поздно, чем никогда. Русский медицинский журнал. 2013; 21(1): 26-30
  3. Серова О.Ф., Мельник Т.Н. Реабилитация после медицинского аборта - путь к сохранению репродуктивного здоровья женщин. Русский медицинский журнал. 2007; 15(17): 1266-70
  4. National Collaborating Centre for Women’s and Children’s Health (UK). Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. London: RCOG Press; 2005 Oct
  5. Blumenthal P.D., Voedisch A., Gemzell-Danielsson K. Strategies to prevent unintended pregnancy: Increasing use of long-acting reversible contraception. Hum. Reprod. Update. 2010; 17(1): 121-37
  6. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: World Health Organization; 2012
  7. American College of Obstetricians and Gynecologists. Long-acting reversible contraception: implants and intrauterine devices. Guideline Summary. 2011 Jul. NGC: 008627. Available at: http://www.guideline.gov/
  8. Bellagio consensus recommendations for action to increase access to highly effective, long-acting, reversible contraception. Statement. 2012. Available at: http://www.astra.org
  9. Faculty of Sexual and Reproductive Healthcare - Professional Association. Contraceptive choices for young people. Guideline Summary. 2010. NGC: 008192. Available at: http://www.guideline.gov/
  10. Faculty of Sexual and Reproductive Healthcare - Professional Association. Progestogen-only implants. Guideline Summary. 2008. NGC: 006465. Available at: http://www.guideline.gov/
  11. Grimes D.A., Lopez L.M., Schulz K.F., Stanwood N.L. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst. Rev. 2010; (6): CD001777. Available at: http://www.cochrane.org/
  12. Post-abortion family planning: a practical guide for programme managers. Geneva: World Health Organization; 2011
  13. Sonfield А. Abortion clinics and contraceptive services: Opportunities and challenges. Guttmacher Policy Rev. Spring 2011; 14(2). Available at: http://www.guttmacher.org/
  14. Stanwood N.L., Grimes D.A., Schulz K.F. Insertion of an intrauterine contraceptive device after induced or spontaneous abortion: a review of the evidence. Br. J. Obstet. Gynaecol. 2001; 108(11): 1168-73
  15. Прилепская В.Н., Тарасова М.А., Назарова Н.М., Летуновская А.Б. Международный проект «CHOICE»: краткий обзор результатов исследования. Гинекология. 2010; 12(4): 26-8. Available at: http://www.consilium-medicum.com/
  16. Winner B., Peipert J.F., Zhao Q., Buckel C., Madden T., Allsworth J.E., Secura G.M. Effectiveness of long-acting reversible contraception. N. Engl. J. Med. 2012; 366 (21): 1998-2007
  17. Peipert J.F., Madden T., Allsworth J.E., Secura G.M. Preventing unintended pregnancies by providing no-cost contraception. Obstet. Gynecol. 2012; 120(6): 1291-7
  18. Faculty of Sexual and Reproductive Healthcare - Professional Association. Postnatal sexual and reproductive health. Guideline Summary. 2009. NGC: 007644. Available at: http://www.guideline.gov/
  19. El-Tagy A., Sakr E., Sokal D.C., Issa A.H. Safety and acceptability of postabortal IUD insertion and the importance of counseling. Contraception. 2003; 67(3): 229-34
  20. World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: World Health Organization, Reproductive Health and Research; 2010
  21. Национальные медицинские критерии приемлемости методов контрацепции. Адаптированный документ «Медицинские критерии приемлемости использования методов контрацепции. 4 изд. ВОЗ; 2009». М.: ВОЗ; 2012. 178 с
  22. Secura G.M., Allsworth J.E., Madden T., Mullersman J.L., Peipert J.F. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am. J. Obstet. Gynecol. 2010; 203(2): 115. e1-7
  23. Горшков М. Российское общество как оно есть (опыт социологической диагностики). М.: Новый хронограф; 2011. 672 с
  24. Trussell J. Contraceptive failure in the United States. Contraception. 2011; 84: 397-404
  25. Прилепская В.Н. Руководство по контрацепции. М.: МЕДпресс-информ; 2006. 400 с
  26. Mestad R.E., Kenerson J., Peipert J.F. Reversible contraception update: the importance of long-acting reversible contraception. Postgrad. Med. 2009; 121(4): 18-25
  27. Rowan S.P., Someshwar J., Murray P. Contraception for primary care providers. Adolesc. Med. State Art Rev. 2012; 23(1): 95-110
  28. Радзинский В.Е., Оразмурадов А.А., ред. Ранние сроки беременности. 2-е изд. М.: Медиабюро Status Praesens; 2009. 480 с
  29. Schreiber C.A., Sober S., Ratcliffe S., Creinin M. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011; 84: 230-3.
  30. Lähteenmäki P., Luukkainen T. Return of ovarian function after abortion. Clin. Endocrinol. (Oxf). 1978; 8(2): 123-32.
  31. Lähteenmäki P. The disappearance of HCG and return of pituitary function after abortion. Clin. Endocrinol.(Oxf). 1978; 9(2): 101-12.
  32. Lähteenmäki P. Return of ovulation after abortion and after discontinuation of oral contraceptives. Fertil. Steril.1980; 34(3): 246.
  33. Osotimehin B., Otolorin E.O., Ladipo O.A. Sequential hormone measurements after first trimester abortion in normal Nigerian women. Adv. Contracept. 1985; 1(1): 83-90.
  34. Sääv I., Stephansson O., Gemzell-Danielsson K. Early versus delayed insertion of intrauterine contraception after medical abortion - a randomized controlled trial. PLoS One. 2012; 7(11): e48948.
  35. Rose S.B., Lawton B.A., Brown S.A. Uptake and adherence to long-acting reversible contraception post-abortion. Contraception. 2010; 82(4): 345-53.
  36. Steenland M.W., Tepper N.K., Curtis K.M., Kapp N. Intrauterine contraceptive insertion postabortion: a systematic review. Contraception. 2011;84(5): 447-64.
  37. Stoddard A., McNicholas C., Peipert J.F. Efficacy and safety of long-acting reversible contraception. Drugs. 2011; 71(8): 969-80.
  38. Bednarek P.H., Creinin M.D., Reeves M.F., Cwiak C., Espey E., Jensen J.T.; Post-Aspiration IUD Randomization (PAIR) Study Trial Group. Immediate versus delayed IUD insertion after uterine aspiration. N. Engl. J. Med. 2011; 364(23): 2208-17.
  39. Shimoni N., Davis A., Ramos M., Rosario L., Westhoff C. Timing of copper intrauterine device insertion after medical abortion: a randomized controlled trial. Obstet. Gynecol. 2011; 118(3): 623-8.
  40. Goodman S., Hendlish S.K., Reeves M.F., Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception. 2008; 78: 143-8.
  41. Heikinheimo O., Gissler M., Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception. 2008; 78: 149-54.
  42. Мaars R., Kletzky O., Mishell D. A separate mechanism of gonadotropin recovery after pregnancy termination. J. Clin. Endocrinol. Metab.1981; 52(3): 545-8.
  43. Marrs R.P. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion. Am. J. Obstet. Gynecol. 1979; 135(6): 731.
  44. Blazar A.S. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy. Fertil. Steril. 1980; 33(5): 493.
  45. Аванесян А.Р., Бегларян Г.А. Сравнительная оценка эффективности медикаментозного и хирургического аборта в ранние сроки беременности и оценка восстановления менструальной функции в пос-леабортном периоде. Вопросы теоретической и клинической медицины. 2011; 2: 9-14
  46. Reyniak J.V., Gordon M., Stone M.L., Sedlis A. Endometrial regeneration after voluntary abortion. Obstet. Gynecol. 1975; 45(2): 203-10
  47. Thompson K.M., Speidel J.J., Saporta V., Waxman N.J., Harper C.C. Contraceptive policies affect post-abortion provision of long-acting reversible contraception. Contraception. 2011; 83(1): 41-7

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies